KRAS early testing: consensus initiative and cost-effectiveness evaluation for metastatic colorectal patients in an Italian setting.
about
Modeling companion diagnostics in economic evaluations of targeted oncology therapies: systematic review and methodological checklist.RAS testing and cetuximab treatment for metastatic colorectal cancer: a cost-effectiveness analysis in a setting with limited health resources.Personalized medicine in colorectal cancer diagnosis and treatment: a systematic review of health economic evaluations.
P2860
KRAS early testing: consensus initiative and cost-effectiveness evaluation for metastatic colorectal patients in an Italian setting.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
KRAS early testing: consensus ...... atients in an Italian setting.
@en
KRAS early testing: consensus ...... atients in an Italian setting.
@nl
type
label
KRAS early testing: consensus ...... atients in an Italian setting.
@en
KRAS early testing: consensus ...... atients in an Italian setting.
@nl
prefLabel
KRAS early testing: consensus ...... atients in an Italian setting.
@en
KRAS early testing: consensus ...... atients in an Italian setting.
@nl
P2093
P2860
P50
P1433
P1476
KRAS early testing: consensus ...... atients in an Italian setting.
@en
P2093
Carlo Barone
Carmine Pinto
Francesco Cognetti
Lorenzo Capussotti
P2860
P304
P356
10.1371/JOURNAL.PONE.0085897
P407
P577
2014-01-20T00:00:00Z